Tatva Chintan Pharma Chem Limited (IN:TATVA)
:TATVA
Want to see IN:TATVA full AI Analyst Report?
TATVA Stock Chart & Stats
₹1388.35
-₹14.30(-1.60%)
At close: 4:00 PM EST
₹1388.35
-₹14.30(-1.60%)
Day’s Range― - ―
52-Week Range₹674.00 - ₹1,603.60
Previous CloseN/A
Volume13.99K
Average Volume (3M)12.52K
Market Cap
₹29.73B
Enterprise Value₹30.28B
Total Cash (Recent Filing)₹178.47M
Total Debt (Recent Filing)₹830.13M
Price to Earnings (P/E)51.4
Beta1.07
Next Earnings
May 01, 2026EPS Estimate
6.4Next Dividend Ex-DateN/A
Dividend Yield0.07%
Share Statistics
EPS (TTM)6.80
Shares Outstanding23,392,056
10 Day Avg. Volume25,333
30 Day Avg. Volume12,516
Financial Highlights & Ratios
PEG Ratio-3.55
Price to Book (P/B)2.24
Price to Sales (P/S)4.33
P/FCF Ratio-32.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27
Revenue Forecast (FY)₹6.21B
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetConservative leverage and a robust equity base give the company financial resilience across cycles, supporting supplier and customer confidence, allowing access to capital for strategic investments, and reducing bankruptcy risk. This underpins durable operational continuity and strategic optionality.
Diversified Specialty End MarketsServing multiple B2B end markets with specialty, performance-critical chemicals reduces single-market cyclicality and creates stickiness via long customer qualification cycles. The technical nature of products supports higher switching costs and recurring orders from industrial customers over the medium term.
Operational Cash And MarginsPositive operating cash generation and persistent positive EBIT/EBITDA margins indicate core manufacturing efficiency and cash-conversion capability. This operational cash helps fund working capital and supports operations even while investment is ongoing, improving medium-term sustainability.
Bears Say
Negative Free Cash Flow From CapexSustained negative free cash flow driven by heavy capex pressures liquidity and forces reliance on external financing or equity to fund growth. If capex returns lag expectations, this can constrain dividends, increase financing costs, and impair capital allocation flexibility over the coming quarters.
Revenue Decline And Margin VolatilityA falling top line and volatile net margins weaken predictability of earnings and cash generation. For a specialty-chemicals B2B supplier, this suggests either demand softness or pricing/ cost pressures that can reduce pricing power and investment returns, complicating medium-term planning.
Declining Return On EquityA falling ROE signals deteriorating capital efficiency—new assets or investments may not be producing proportional profits. Over months this can force tougher capital allocation choices, risk dilutive capital raises, and erode investor confidence if improved asset productivity isn't realized.
Tatva Chintan Pharma Chem Limited News
TATVA FAQ
What was Tatva Chintan Pharma Chem Limited’s price range in the past 12 months?
Tatva Chintan Pharma Chem Limited lowest stock price was ₹674.00 and its highest was ₹1603.60 in the past 12 months.
What is Tatva Chintan Pharma Chem Limited’s market cap?
Tatva Chintan Pharma Chem Limited’s market cap is ₹29.73B.
When is Tatva Chintan Pharma Chem Limited’s upcoming earnings report date?
Tatva Chintan Pharma Chem Limited’s upcoming earnings report date is May 01, 2026 which is in 4 days.
How were Tatva Chintan Pharma Chem Limited’s earnings last quarter?
Tatva Chintan Pharma Chem Limited released its earnings results on Jan 21, 2026. The company reported ₹6.8 earnings per share for the quarter, beating the consensus estimate of ₹4.5 by ₹2.3.
Is Tatva Chintan Pharma Chem Limited overvalued?
According to Wall Street analysts Tatva Chintan Pharma Chem Limited’s price is currently Overvalued.
Does Tatva Chintan Pharma Chem Limited pay dividends?
Tatva Chintan Pharma Chem Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.07%. See more information on Tatva Chintan Pharma Chem Limited dividends here
What is Tatva Chintan Pharma Chem Limited’s EPS estimate?
Tatva Chintan Pharma Chem Limited’s EPS estimate is 6.4.
How many shares outstanding does Tatva Chintan Pharma Chem Limited have?
Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding.
What happened to Tatva Chintan Pharma Chem Limited’s price movement after its last earnings report?
Tatva Chintan Pharma Chem Limited reported an EPS of ₹6.8 in its last earnings report, beating expectations of ₹4.5. Following the earnings report the stock price went up 1.363%.
Which hedge fund is a major shareholder of Tatva Chintan Pharma Chem Limited?
Currently, no hedge funds are holding shares in IN:TATVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Technical Analysis
Fineotex Chemical Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
Kiri Industries Limited
―
Punjab Chemicals & Crop Protection Ltd.
―
Yasho Industries Ltd.
―